Ascendis Pharma A/S (NASDAQ:ASND)
| 107.88 Delayed Data As of Dec 08 |  -0.92 / -0.85%Today’s Change | 64.33 Today|||52-Week Range 127.77 | -11.67% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 9.0M | 5.1M | 1.7M | 12.5M | |
| Depreciation And Amortization | 618.8K | 748.9K | 827.9K | 1.0M | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 54.8M | 85.0M | 126.7M | 194.0M | ||
| Research And Development | 44.3M | 72.3M | 111.5M | 164.5M | ||
| Total Operating Expenses | 55.4M | 85.8M | 127.5M | 195.1M | ||
| Non-Operating Expenses | Operating Income | -46.4M | -80.7M | -125.8M | -182.6M | |
| Equity In Earnings | 0.00 | 0.00 | 0.00 | -378.7K | ||
| Other Expenses | 9.1M | 4.5M | -15.5M | 24.3M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -37.2M | -76.0M | -140.3M | -153.6M | |
| Income Taxes | -723.0K | -251.1K | -538.0K | -464.8K | ||
| Net Income | -36.5M | -75.8M | -139.7M | -153.5M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 23.8M | 26.6M | 33.6M | 41.1M | |
| Shares To Calculate EPS Diluted | 23.8M | 26.6M | 33.6M | 41.1M | ||
| Earnings Per Share | EPS | -$1.54 | -$2.85 | -$4.15 | -$3.74 | |
| EPS Diluted | -$1.54 | -$2.85 | -$4.15 | -$3.74 | ||
